[go: up one dir, main page]

CO5650216A2 - Estuche para uso farmaceutico - Google Patents

Estuche para uso farmaceutico

Info

Publication number
CO5650216A2
CO5650216A2 CO05092523A CO05092523A CO5650216A2 CO 5650216 A2 CO5650216 A2 CO 5650216A2 CO 05092523 A CO05092523 A CO 05092523A CO 05092523 A CO05092523 A CO 05092523A CO 5650216 A2 CO5650216 A2 CO 5650216A2
Authority
CO
Colombia
Prior art keywords
nutrient
administered
once
active ingredient
active
Prior art date
Application number
CO05092523A
Other languages
English (en)
Inventor
Richard James Cawthray
Vincent Anthony Difabritus
Ellen Mary Loughren
Kurt Franklin Trombley
Der Geest Stephanus Alexander Paulus Van
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33131725&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO5650216(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of CO5650216A2 publication Critical patent/CO5650216A2/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A61J7/04Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • A61J1/035Blister-type containers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medical Informatics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Accommodation For Nursing Or Treatment Tables (AREA)
  • Exchange Systems With Centralized Control (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Packages (AREA)
  • Telephone Function (AREA)

Abstract

1.- Un estuche para promover la administración oral secuencial apropiada de un ingrediente farmacéuticamente activo y nutrientes acompañantes; el estuche se caracteriza por:a) Al menos una dosis unitaria de un activo farmacéutico para ser administrada R2 se selecciona independientemente de hidrógeno, halo, ciano, hidroxilo, carboxi, ceto, tioceto, aminada continuamente con una frecuencia de una vez por semana, dos veces por semana, una vez cada dos semanas, dos veces al mes, o una ves al mes;b) al menos una dosis unitaria de un nutriente para ser administrado subsiguiente a la administración de la dosis del activo; y c) un envase blister que contiene las dosis unitarias individualmente y en forma que se pueda liberar;caracterizado porque las dosis unitarias del activo farmacéutico y el nutriente están dispuestos horizontal o verticalmente siguiendo el orden de su uso de un extremo a otro del envase blister.
CO05092523A 2003-03-26 2005-09-13 Estuche para uso farmaceutico CO5650216A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45786503P 2003-03-26 2003-03-26

Publications (1)

Publication Number Publication Date
CO5650216A2 true CO5650216A2 (es) 2006-06-30

Family

ID=33131725

Family Applications (1)

Application Number Title Priority Date Filing Date
CO05092523A CO5650216A2 (es) 2003-03-26 2005-09-13 Estuche para uso farmaceutico

Country Status (27)

Country Link
US (2) US20040188316A1 (es)
EP (1) EP1605890B1 (es)
JP (1) JP4865332B2 (es)
KR (1) KR100775795B1 (es)
CN (1) CN100493486C (es)
AT (1) ATE526003T1 (es)
AU (1) AU2004226326B2 (es)
BR (1) BRPI0408770B1 (es)
CA (1) CA2517102A1 (es)
CO (1) CO5650216A2 (es)
CY (1) CY1112964T1 (es)
DK (1) DK1605890T5 (es)
ES (1) ES2374273T3 (es)
HK (1) HK1086737A1 (es)
HR (1) HRP20050824B1 (es)
HU (1) HU3526U (es)
IL (1) IL170830A (es)
IS (1) IS2883B (es)
MA (1) MA27723A1 (es)
MX (1) MXPA05010198A (es)
NO (1) NO333084B1 (es)
NZ (1) NZ541856A (es)
PL (1) PL1605890T3 (es)
PT (1) PT1605890E (es)
RU (1) RU2314786C2 (es)
SI (1) SI1605890T1 (es)
WO (1) WO2004087038A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2294203C2 (ru) * 2001-12-21 2007-02-27 Дзе Проктер Энд Гэмбл Компани Способ лечения костных нарушений
US20050070504A1 (en) * 2001-12-21 2005-03-31 The Procter & Gamble Co. Risedronate compositions and their methods of use
US20070095850A1 (en) * 2005-10-27 2007-05-03 Meyer Daniel D Multiple medication dispensing system
KR100844256B1 (ko) * 2007-03-23 2008-07-07 코오롱제약주식회사 리세드로네이트와 비타민 d를 포함하는 대사성 골질환치료용 약제조성물 및 이의 제조방법
WO2009087553A1 (en) * 2008-01-02 2009-07-16 Aurobindo Pharma Limited Kits for administering bisphosphonates
EP2082717A1 (en) 2008-01-28 2009-07-29 Merz Pharma GmbH & Co. KGaA Titration package
TR200900879A2 (tr) * 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Aktif maddelerin tek bir dozaj formunda kombine edildiği farmasötik bileşimler
TR200900880A2 (tr) * 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tek bir dozaj formunda kombine edilen farmasötik bileşimler.
US8377454B2 (en) * 2009-05-01 2013-02-19 Parviz Gharagozloo Treating male infertility secondary to sperm oxidative stress
US20160132658A1 (en) * 2014-11-09 2016-05-12 Bhuren Patel Novel multi-compartment dosage cards for split package administration
WO2017196201A1 (ru) * 2016-05-10 2017-11-16 Анатолий Викторович ЗАЗУЛЯ Устройство для пожизненного приёма переменных доз геропротектора, повышения постадаптации гормезис

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL58649A (en) * 1978-11-10 1982-04-30 Beecham Group Ltd Pharmaceutical dispensing container
US4534468A (en) * 1983-12-19 1985-08-13 Nuckols Walter S Calendar-oriented pill dispenser
US4736849A (en) * 1983-12-19 1988-04-12 Leonard Walter G Calendar-oriented pill dispenser
US4817819A (en) * 1985-12-19 1989-04-04 Berlex Laboratories, Inc. Container for tablets
US4958736A (en) * 1986-03-18 1990-09-25 Gynex, Inc. Package for oral contraceptive tablet
US4889238A (en) * 1989-04-03 1989-12-26 The Procter & Gamble Company Medicament package for increasing compliance with complex therapeutic regimens
US5265728A (en) * 1991-04-29 1993-11-30 Berlex Laboratories, Inc. Arrangement for retaining blister pack tablets
CA2067611A1 (en) 1991-04-29 1992-10-30 Stephan Charles Allendorf Arrangement for retaining blister pack tablets
US5366965A (en) * 1993-01-29 1994-11-22 Boehringer Mannheim Gmbh Regimen for treatment or prophylaxis of osteoporosis
US5484976A (en) * 1993-10-01 1996-01-16 Axis Usa, Inc. Fusing methods and apparatus for use in making dynamo-electric machines
SE9502370D0 (sv) * 1995-06-30 1995-06-30 Astra Ab Blister pack, especially for drugs, as well as method and device in manufacturing the same
SE515129C2 (sv) * 1996-07-01 2001-06-11 Astrazeneca Ab Blisterförpackning, apparat och förfarande för tillverkning av en blisterförpackning samt användning av en blisterförpackning
US5788974A (en) * 1996-09-11 1998-08-04 D'amico; Steven A. Helicobacter pylori treatment compliance pack
US6564945B1 (en) * 1997-07-14 2003-05-20 Robert E. Weinstein Medication assemblage for use in sinusitis treatment regimens
US5994329A (en) * 1997-07-22 1999-11-30 Merck & Co., Inc. Method for inhibiting bone resorption
EP1032392A4 (en) * 1997-10-29 2001-05-09 J Med Pharmaceuticals Inc RHINITIS TREATMENT BY ANTIHISTAMINE / DECONGESTIVUM ADMINISTRATION
WO1999051214A2 (en) 1998-04-07 1999-10-14 Akzo Nobel N.V. Progestogen-only contraceptive kit
US6375956B1 (en) * 1999-07-22 2002-04-23 Drugtech Corporation Strip pack
AU2270101A (en) * 1999-12-20 2001-07-03 Merck & Co., Inc. Pharmaceutical kit
US20020066691A1 (en) * 2000-12-04 2002-06-06 Varon Steven C. Therapy pack
US6651816B2 (en) * 2001-05-04 2003-11-25 Robert E. Weinstein Antihistamine/decongestant regimens for treating rhinitis
AU2002331013A1 (en) * 2001-08-09 2003-02-24 Rhodia Inc. Calcium dietary supplement
US20030111479A1 (en) * 2001-12-19 2003-06-19 Rajneesh Taneja Packaging system for separately storing and dispensing together separate medication components
US20030168376A1 (en) * 2001-12-19 2003-09-11 Rajneesh Taneja Packaging system for separately storing and dispensing together separate medication components

Also Published As

Publication number Publication date
ES2374273T3 (es) 2012-02-15
EP1605890A1 (en) 2005-12-21
JP4865332B2 (ja) 2012-02-01
NO333084B1 (no) 2013-02-25
JP2006520615A (ja) 2006-09-14
CY1112964T1 (el) 2016-04-13
PT1605890E (pt) 2011-12-21
ATE526003T1 (de) 2011-10-15
NO20054204L (no) 2005-09-09
US20040188316A1 (en) 2004-09-30
SI1605890T1 (sl) 2012-02-29
MXPA05010198A (es) 2005-11-08
PL1605890T3 (pl) 2012-02-29
NZ541856A (en) 2007-03-30
RU2314786C2 (ru) 2008-01-20
KR100775795B1 (ko) 2007-11-12
BRPI0408770B1 (pt) 2021-06-01
HU0600225V0 (en) 2006-11-28
MA27723A1 (fr) 2006-01-02
CN100493486C (zh) 2009-06-03
HRP20050824B1 (hr) 2014-01-17
HRP20050824A2 (en) 2006-02-28
AU2004226326A1 (en) 2004-10-14
CA2517102A1 (en) 2004-10-14
IS8022A (is) 2005-09-12
DK1605890T3 (da) 2011-11-28
IS2883B (is) 2014-06-15
BRPI0408770A (pt) 2006-04-04
HK1086737A1 (en) 2006-09-29
AU2004226326B2 (en) 2008-04-17
RU2005129534A (ru) 2006-02-27
IL170830A (en) 2013-04-30
US20120145588A1 (en) 2012-06-14
DK1605890T5 (da) 2012-01-23
WO2004087038A1 (en) 2004-10-14
KR20050111610A (ko) 2005-11-25
EP1605890B1 (en) 2011-09-28
HU3526U (en) 2008-12-29
CN1764430A (zh) 2006-04-26

Similar Documents

Publication Publication Date Title
CY1112964T1 (el) Κιτ για φαρμακευτικη χρηση
RU2356547C2 (ru) Способы лечения рака с использованием ингибиторов hdac
IT1261849B (it) Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici.
RU2010133489A (ru) Применение ингибиторов гамма-секретазы для лечения рака
MX2009004871A (es) Paquete de dosificacion unitaria y metodos para administrar medicaciones de perdida de peso.
WO2007012019A3 (en) Medicaments containing famotidine and ibuprofen and administration of same
AR037592A1 (es) Formulaciones farmaceuticas de 5,7,14-triazatetraciclo (10.3.1.02,11.04,9)-hexadeca-2(11),3,5,7,9-pentaeno
RU2007132181A (ru) ПРОТИВОРАКОВОЕ ЛЕКАРСТВЕННОЕ СРЕДСТВО, СОДЕРЖАЩЕЕ α,α,α-ТРИФТОРТИМИДИН И ИНГИБИТОР ТИМИДИНФОСФОРИЛАЗЫ
DE60022021D1 (de) Zubereitungen enthaltend Apomorphin und Sildenafil und ihre Verwendung zur Behandlung von erektiler Dysfunktion
JP2006504795A5 (es)
AR034813A1 (es) Composiciones farmaceuticas y uso de las mismas
CA2570474A1 (en) A combination composition comprising paracetamol and ibuprofen
IL153288A0 (en) Use of growth hormone or a derivative thereof in the preparation of a medicament for hematopoiesis
RU2011111792A (ru) Применение парацетамола и ибупрофена в лечении
RU2010109359A (ru) Азитромицин для лечения кожных заболеваний
BRPI0413374A (pt) composições para liberação de base fraca por um perìodo estendido de tempo
DE69803670D1 (de) Tiagabinhaltige arzneizubereitungen mit gesteuerter wirkstoffverabreichung
GB0018322D0 (en) Pharmaceutical compositions
AR030551A1 (es) Uso de nefiracetam para la fabricacion de un medicamento para eltratamiento de la neurodegeneracion y composicion farmaceutica resultante
AR046042A1 (es) Kit para uso farmaceutico
RU2002129356A (ru) Комбинация лекарственных средств для лечения головной боли, содержащая нестероидное противовоспалительное лекарственное средство
ATE494239T1 (de) Vorrichtung zum abgeben von pharmazeutischen produkten
ES2211374T1 (es) Dosificacion metronomica de taxanos para inhibir el crecimiento tumoral.
DE59908258D1 (de) Blister enthaltend ein transdermales therapeutisches system und eine einzeldosierte darreichungsform
RU2007128308A (ru) НОВОЕ ПРИМЕНЕНИЕ РЕКОМБИНАНТА АДЕНОВИРУСА р-53 ДЛЯ ЛЕЧЕНИЯ РАКОВЫХ ПАЦИЕНТОВ

Legal Events

Date Code Title Description
FC Application refused